Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment

Survival outcomes for patients with high-risk neuroblastoma (NB) have significantly improved with anti-disialoganglioside GD2 mAb therapy, which promotes NK cell activation through antibody-dependent cell-mediated cytotoxicity. NK cell activation requires an interaction between inhibitory killer cel...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Tarek, Nidale, Le Luduec, Jean-Benoit, Gallagher, Meighan M., Zheng, Junting, Venstrom, Jeffrey M., Chamberlain, Elizabeth, Modak, Shakeel, Heller, Glenn, Dupont, Bo, Cheung, Nai-Kong V., Hsu, Katharine C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Clinical Investigation 2012
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3428088/
https://ncbi.nlm.nih.gov/pubmed/22863621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI62749
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller